ArticleBlood2020
Leveraging gene expression subgroups to classify DLBCL patients and select for clinical benefit from a novel agent.
Alberto Risueño et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it